Alisabet Clain

1.2k total citations
31 papers, 890 citations indexed

About

Alisabet Clain is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Alisabet Clain has authored 31 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 11 papers in Experimental and Cognitive Psychology and 8 papers in Psychiatry and Mental health. Recurrent topics in Alisabet Clain's work include Treatment of Major Depression (17 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Mental Health Research Topics (6 papers). Alisabet Clain is often cited by papers focused on Treatment of Major Depression (17 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Mental Health Research Topics (6 papers). Alisabet Clain collaborates with scholars based in United States, South Korea and Germany. Alisabet Clain's co-authors include Lee Baer, Maurizio Fava, David Mischoulon, George I. Papakostas, Jonathan E. Alpert, Andrew A. Nierenberg, Nadia Iovieno, Adrienne van Nieuwenhuizen, Albert Yeung and Michael A. Rex and has published in prestigious journals such as American Journal of Psychiatry, Evolution and Journal of Affective Disorders.

In The Last Decade

Alisabet Clain

31 papers receiving 854 citations

Peers

Countries citing papers authored by Alisabet Clain

Since Specialization

Citations

This map shows the geographic impact of Alisabet Clain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alisabet Clain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alisabet Clain more than expected).

Fields of papers citing papers by Alisabet Clain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alisabet Clain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alisabet Clain. The network helps show where Alisabet Clain may publish in the future.

Co-authorship network of co-authors of Alisabet Clain

This figure shows the co-authorship network connecting the top 25 collaborators of Alisabet Clain. A scholar is included among the top collaborators of Alisabet Clain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alisabet Clain. Alisabet Clain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation 2022 ·The Journal of Clinical Psychiatry ·David Mischoulon, Boadie W. Dunlop, Becky Kinkead, Pamela J. Schettler, Stefania Lamon‐Fava, Jeffrey J. Rakofsky, Andrew A. Nierenberg, Alisabet Clain, Tanja Mletzko, Andrea Li Ann Wong, Jennifer C. Felger, (unknown), Thomas R. Ziegler, Cristina Cusin, Lauren Fisher, Maurizio Fava, Mark Hyman Rapaport	41
2	Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder 2022 ·The Journal of Clinical Psychiatry ·Dan V. Iosifescu, (unknown), Ümit Tural, David Mischoulon, Katherine A. Collins, Erin McDonald, Luis De Taboada, Simmie L. Foster, Cristina Cusin, Albert Yeung, Alisabet Clain, David Schoenfeld, Michael R. Hamblin, Paolo Cassano	24
3	Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression 2018 ·Frontiers in Psychiatry ·Johannes A. C. Laferton, (unknown), Lee Baer, Alisabet Clain, (unknown), George I. Papakostas, Lawrence H. Price, Linda L. Carpenter, Audrey R. Tyrka, Maurizio Fava, David Mischoulon	16
4	The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants 2016 ·The Journal of Clinical Psychiatry ·Albert Yeung, (unknown), Lee Baer, Justin A. Chen, Alisabet Clain, (unknown), Trina Chang, (unknown), Jonathan E. Alpert, Maurizio Fava	25
5	The Effects of Tai Chi on Sleep Quality in Chinese American Patients With Major Depressive Disorder: A Pilot Study 2016 ·Behavioral Sleep Medicine ·Yan Ma, (unknown), Albert C. Yang, Chung‐Kang Peng, Alisabet Clain, Jonathan E. Alpert, Maurizio Fava, Albert Yeung	13
6	Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial 2015 ·Journal of Psychiatric Research ·Jung-Yoon Heo, Hong Jin Jeon, Maurizio Fava, David Mischoulon, Lee Baer, Alisabet Clain, James Doorley, Angela Pisoni, George I. Papakostas	5
7	Association between physician beliefs regarding assigned treatment and clinical response: Re-analysis of data from the Hypericum Depression Trial Study Group 2014 ·Asian Journal of Psychiatry ·Justin A. Chen, (unknown), George I. Papakostas, Susannah R. Parkin, (unknown), Cristina Cusin, Lee Baer, Alisabet Clain, Maurizio Fava, David Mischoulon	11
8	A Double-Blind, Randomized, Placebo-Controlled Clinical Trial ofS-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder 2013 ·The Journal of Clinical Psychiatry ·David Mischoulon, Lawrence H. Price, Linda L. Carpenter, Audrey R. Tyrka, George I. Papakostas, Lee Baer, Christina Dording, Alisabet Clain, (unknown), Rosemary Walker, Elizabeth Ludington, Maurizio Fava	69
9	Differences in depressive symptoms between Korean and American outpatients with major depressive disorder 2013 ·International Clinical Psychopharmacology ·Hong Jin Jeon, Rosemary S. Walker, (unknown), Jin Pyo Hong, Maeng Je Cho, Lee Baer, Alisabet Clain, Maurizio Fava, David Mischoulon	50
10	l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials 2012 ·American Journal of Psychiatry ·George I. Papakostas, Richard C. Shelton, John Zajecka, Bijan Etemad, Karl Rickels, Alisabet Clain, Lee Baer, Elizabeth D. Dalton, (unknown), David Schoenfeld, Michael Pencina, Allison Meisner, Teodoro Bottiglieri, Erik Nelson, David Mischoulon, Jonathan E. Alpert, James G. Barbee, Sidney Zisook, Maurizio Fava	182
11	A Randomized, Controlled, Pilot Study of Acamprosate Added to Escitalopram in Adults With Major Depressive Disorder and Alcohol Use Disorder 2012 ·Journal of Clinical Psychopharmacology ·(unknown), Kate H. Bentley, A. Eden Evins, Alisabet Clain, Lee Baer, Paola Pedrelli, Maurizio Fava, David Mischoulon	16
12	Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response 2011 ·The Journal of Clinical Psychiatry ·Justin A. Chen, George I. Papakostas, Soo Jeong Youn, Lee Baer, Alisabet Clain, Maurizio Fava, David Mischoulon	39
13	Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St Johnʼs wort (Hypericum perforatum) versus a SSRI 2011 ·International Clinical Psychopharmacology ·Stella Bitran, Amy Farabaugh, Victoria Ameral, (unknown), Alisabet Clain, Maurizio Fava, David Mischoulon	11
14	Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse 2010 ·Depression and Anxiety ·Nadia Iovieno, Adrienne van Nieuwenhuizen, Alisabet Clain, Lee Baer, Andrew A. Nierenberg	74
15	Psychoticism and Paranoid Ideation in Patients With Nonpsychotic Major Depressive Disorder: Prevalence, Response to Treatment, and Impact on Short- and Long-Term Treatment Outcome 2010 ·CNS Spectrums ·Christina Dording, David Mischoulon, (unknown), Lee Baer, Alisabet Clain, Jonathan W. Stewart, John Matthews, Patrick J. McGrath, Andrew A. Nierenberg, Maurizio Fava, George I. Papakostas	1
16	Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome 2010 ·International Clinical Psychopharmacology ·Amy Farabaugh, Stella Bitran, (unknown), Jonathan E. Alpert, Sarah Chuzi, Alisabet Clain, Lee Baer, Maurizio Fava, Patrick J. McGrath, Christina Dording, David Mischoulon, George I. Papakostas	35
17	Examining the role of race and ethnicity in relapse rates of major depressive disorder 2010 ·Comprehensive Psychiatry ·Nhi‐Ha Trinh, Irene Shyu, Patrick J. McGrath, Alisabet Clain, Lee Baer, Maurizio Fava, Albert Yeung	4
18	Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study 2009 ·International Clinical Psychopharmacology ·George I. Papakostas, Alisabet Clain, Victoria Ameral, Lee Baer, Carrie Brintz, Ward T. Smith, Peter D. Londborg, Vincent Glaudin, John R. Painter, Maurizio Fava	16
19	Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine 2009 ·European Archives of Psychiatry and Clinical Neuroscience ·Huaiyu Yang, Sarah Chuzi, (unknown), (unknown), Ying Chen, Alisabet Clain, Lee Baer, Patrick J. McGrath, Jonathan W. Stewart, Maurizio Fava, George I. Papakostas	31
20	Compact and trabecular components of the spine using quantitative computed tomography 1992 ·Calcified Tissue International ·Tamás Sándor, Dieter Felsenberg, Willi A. Kalender, Alisabet Clain, Edward B. Brown	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact